The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

The SARAH trial was limited to high-risk patients, which the lead investigator said prevented unnecessary exposure to adverse ...

Among four approaches, perioperative chemotherapy and trimodality therapy were associated with better survival outcomes in ...

In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...

A widely used heart failure medication called sacubitril/valsartan was associated with a lower risk of heart damage compared ...

Selective Targeting and Reduction of CD19+ B Cells Observed with Each FT522 Dose in Study's First Low-dose Cohort without ...

The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...

Evie is receiving a chemotherapy treatment plan that is a result of decades of donor supported clinical trials. Donations ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...

"When you know that your granddaughter, who at that point wasn't even a year old, has already done that treatment, it made me ...